Letter by Carmona et al Regarding Article, "Beneficial Effect of Statins in COVID-19-Related Outcomes-Brief Report: a National Population-Based Cohort Study"
Arterioscler Thromb Vasc Biol
.
2021 May 5;41(5):e280-e281.
doi: 10.1161/ATVBAHA.121.316224.
Epub 2021 Apr 21.
Authors
Adrien Carmona
1
,
Benjamin Marchandot
1
,
Kensuke Matsushita
1
2
,
Olivier Morel
1
2
Affiliations
1
Division of Cardiovascular Medicine, Strasbourg University Hospital, France (A.C., B.M., K.M., O.M.).
2
French National Institute of Health and Medical Research, UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France (K.M., O.M.).
PMID:
33881925
DOI:
10.1161/ATVBAHA.121.316224
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Cohort Studies
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
SARS-CoV-2
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors